Cargando…
Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
OBJECTIVE—: Diabetes mellitus involves vascular inflammatory processes and is a main contributor to cardiovascular mortality. Notably, heightened levels of circulating tissue factor (TF) account for the increased thrombogenicity and put those patients at risk for thromboembolic events. Here, we soug...
Autores principales: | Witkowski, Marco, Weithauser, Alice, Tabaraie, Termeh, Steffens, Daniel, Kränkel, Nicolle, Witkowski, Mario, Stratmann, Bernd, Tschoepe, Diethelm, Landmesser, Ulf, Rauch-Kroehnert, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894779/ https://www.ncbi.nlm.nih.gov/pubmed/27127202 http://dx.doi.org/10.1161/ATVBAHA.115.306094 |
Ejemplares similares
-
MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes
por: Witkowski, Marco, et al.
Publicado: (2018) -
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
por: Witkowski, Marco, et al.
Publicado: (2020) -
Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes
por: Witkowski, Marco, et al.
Publicado: (2020) -
Galectin-3 as a Marker for Increased Thrombogenicity in COVID-19
por: Puccini, Marianna, et al.
Publicado: (2023) -
Artificial sweetener sucralose: a possible modulator of autoimmune diseases
por: Kränkel, Nicolle, et al.
Publicado: (2023)